Tamuzimod

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameTamuzimod
Drug Alias NameVTX-002OPL-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 modulators
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[17
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOppilan Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A